(3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Term ID

CHEBI:152908

Synonyms

alpha-D-gluco-hexopyranosyl-(1->6)-D-gluco-hexopyranosyl-(1->2)-D-gluco-hexopyranose
Glc(a1-6)Glc(?1-2)Glc

Definition

References

glygen:G64623GC
glytoucan:G64623GC

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype where environments contain (3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype modified by environments containing (3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Phenotype affecting (3R,4S,5S,6R)-6-(Hydroxymethyl)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,4,5-triol

Human Disease Model